About Mangrove Therapeutics
Mangrove Therapeutics is a private company based in Sacramento, California, incorporated in 2025 in Delaware. It has reported $2,455,000 raised in one offering on Form D since July 2026. Its chief executive is Benjamin Chen.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 21, 2026 | Jul 31, 2026 | $2,455,000of $5.0M target | 9 | $272K | Simple Agreement for Future Equity (SAFE)Rule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Mangrove Therapeutics's Form D filed Jul 31, 2026.
JL
Jin Li
Director
BC
Benjamin Chen
Chief Executive Officer (Interim) / President and director
AG
Alexander Green
Secretary